[HTML][HTML] Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine

DK Tobias, J Merino, A Ahmad, C Aiken, JL Benham…�- Nature medicine, 2023 - nature.com
Precision medicine is part of the logical evolution of contemporary evidence-based medicine
that seeks to reduce errors and optimize outcomes when making medical decisions and�…

Prevention of Cardiovascular Disease in Type 1 Diabetes

C Manrique-Acevedo, IB Hirsch…�- New England Journal of�…, 2024 - Mass Medical Soc
Prevention of Cardiovascular Disease in Type 1 Diabetes | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search�…

[HTML][HTML] Precision subclassification of type 2 diabetes: a systematic review

S Misra, R Wagner, B Ozkan, M Sch�n…�- Communications�…, 2023 - nature.com
Background Heterogeneity in type 2 diabetes presentation and progression suggests that
precision medicine interventions could improve clinical outcomes. We undertook a�…

The American Heart Association at 100: a century of scientific progress and the future of cardiovascular science: a Presidential Advisory From the American Heart�…

MSV Elkind, DK Arnett, IJ Benjamin, RH Eckel…�- Circulation, 2024 - Am Heart Assoc
In 1924, the founders of the American Heart Association (AHA) envisioned an international
society focused on the heart and aimed at facilitating research, disseminating information�…

20-year trends in metabolic syndrome among Korean adults from 2001 to 2020

D Park, MJ Shin, JP Despr�s, RH Eckel, J Tuomilehto…�- JACC: Asia, 2023 - jacc.org
Background The number of people with metabolic syndrome (MetS) is increasing worldwide,
and many socioeconomic and environmental factors contribute to this. Objectives The�…

[HTML][HTML] Lipid-lowering in diabetes: An update

A Chait, RH Eckel, M Vrablik, A Zambon�- Atherosclerosis, 2023 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) is accelerated in people with diabetes.
Dyslipidemia, hyperglycemia, oxidative stress, and inflammation play a role via a variety of�…

Cardio‐renal‐metabolic disease in primary care setting

M Ibrahim, EM Ba‐Essa, J Baker…�- Diabetes/metabolism�…, 2024 - Wiley Online Library
In the primary care setting providers have more tools available than ever before to impact
positively obesity, diabetes, and their complications, such as renal and cardiac diseases. It is�…

The Emerging Role of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Metabolic-Dysfunction Associated Steatohepatitis

LA Abushamat, PA Shah, RH Eckel, SA Harrison…�- Clinical�…, 2024 - Elsevier
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects one in three to four
adult individuals and can progress to metabolic dysfunction-associated steatohepatitis�…

[HTML][HTML] DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Y Handelsman, JE Anderson, GL Bakris…�- Metabolism, 2024 - Elsevier
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular�…

A proposal for the comprehensive care of men on androgen deprivation therapy: recommendations from the multidisciplinary Prostate Cancer 360 Working Group

ED Crawford, MB Garnick, RH Eckel, MM Miner…�- Urology�…, 2024 - auajournals.org
Introduction: To promote comprehensive care of patients throughout the androgen
deprivation therapy (ADT) prescribing process, the Prostate Cancer 360 (PC360) Working�…